UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
March 15, 2007
USANA HEALTH SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Commission File No. 0-21116
Utah |
| 87-0500306 |
(State or other jurisdiction of |
| (IRS Employer Identification |
incorporation) |
| Number) |
3838 West Parkway Boulevard |
(Address of principal executive offices, Zip Code) |
Registrant’s telephone number, including area code: (801) 954-7100
Former name or former address, if changed since last report: Not Applicable
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 |
| Other Events |
On March 15th, 2007, USANA Health Sciences, Inc. issued a press release announcing that it has filed a lawsuit against the Fraud Discovery Institute and Barry Minkow in U.S. District Court in Salt Lake City, Utah for defamation. The release also included a statement from the company regarding public claims made by Mr. Minkow. A copy of the press release is furnished herewith as Exhibit 99 to this Current Report on Form 8-K and is incorporated herein by reference. The company will also post this document on its corporate website, www.usanahealthsciences.com, under the “investors” link.
Item 9.01 |
| Financial Statements and Exhibits |
|
|
|
|
| (d) Exhibits |
|
|
|
Exhibit 99 |
| Press release issued by USANA Health Sciences, Inc. dated March 15, 2007 (furnished herewith). |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
USANA HEALTH SCIENCES, INC. | |||
|
| ||
|
| ||
| By: | /s/ Gilbert A. Fuller |
|
| Gilbert A. Fuller, Chief Financial Officer | ||
|
| ||
Date: March 20, 2007 |
| ||
3